Melatonin in Alzheimer's disease and other neurodegenerative disorders

Melatonin in Alzheimer's disease and other neurodegenerative disorders

<p>Abstract</p> <p>Increased oxidative stress and mitochondrial dysfunction have been identified as common pathophysiological phenomena associated with neurodegenerative disorders such as Alzheimer's disease (AD), Parkinson's disease (PD) and Huntington's disease (HD...

Full description

Bibliographic Details
Main Authors:	Poeggeler B, Cardinali DP, Pandi-Perumal SR, Srinivasan V, Hardeland R
Format:	Article
Language:	English
Published:	BMC 2006-05-01
Series:	Behavioral and Brain Functions
Online Access:	http://www.behavioralandbrainfunctions.com/content/2/1/15

Similar Items

Melatonin’s Benefits and Risks as a Therapy for Sleep Disturbances in the Elderly: Current Insights
by: Cardinali DP, et al.
Published: (2022-10-01)

Melatonin, a potent agent in antioxidative defense: Actions as a natural food constituent, gastrointestinal factor, drug and prodrug
by: Pandi-Perumal SR, et al.
Published: (2005-09-01)

Therapeutic potential of melatonin and its analogs in Parkinson’s disease: focus on sleep and neuroprotection
by: Venkatramanujam Srinivasan, et al.
Published: (2011-09-01)

Drug repurposing for Alzheimer’s disease and other neurodegenerative disorders
by: Jeffrey L. Cummings, et al.
Published: (2025-02-01)

Possible Application of Melatonin in Long COVID
by: Daniel P. Cardinali, et al.
Published: (2022-11-01)

Melatonin receptor agonists in neurodegenerative diseases and psychiatric disorders
by: Nicola Dyrek, et al.
Published: (2024-09-01)

Melatonin Therapy in Patients with Alzheimer’s Disease
by: Daniel P. Cardinali, et al.
Published: (2014-04-01)

Can Melatonin Be a Potential “Silver Bullet” in Treating COVID-19 Patients?
by: Daniel P. Cardinali, et al.
Published: (2020-11-01)

DNA Methylation: A Promising Approach in Management of Alzheimer’s Disease and Other Neurodegenerative Disorders
by: Gagandeep Kaur, et al.
Published: (2022-01-01)

Sex-dependent effect of APOE on Alzheimer's disease and other age-related neurodegenerative disorders
by: Julia Gamache, et al.
Published: (2020-08-01)

The role of structural variations in Alzheimer’s disease and other neurodegenerative diseases
by: Hui Wang, et al.
Published: (2023-02-01)

Mitophagy in Alzheimer’s Disease and Other Age-Related Neurodegenerative Diseases
by: Qian Cai, et al.
Published: (2020-01-01)

Optical Coherence Tomography in Alzheimer’s Disease and Other Neurodegenerative Diseases
by: Jonah Doustar, et al.
Published: (2017-12-01)

Molecular Role of Protein Phosphatases in Alzheimer’s and Other Neurodegenerative Diseases
by: Mubashir Hassan, et al.
Published: (2024-05-01)

Cerebellum in Alzheimer's disease and other neurodegenerative diseases: an emerging research frontier
by: Cui Yang, et al.
Published: (2024-07-01)

Plants from Ayurveda medicine used in treatment of Alzheimer's and other neurodegenerative disorders
by: Donika Hoxha, et al.
Published: (2024-12-01)

Fluid Biomarkers in Alzheimer’s Disease and Other Neurodegenerative Disorders: Toward Integrative Diagnostic Frameworks and Tailored Treatments
by: Linda Giampietri, et al.
Published: (2022-03-01)

Disparity of smell tests in Alzheimer’s disease and other neurodegenerative disorders: a systematic review and meta-analysis
by: Silin Liu, et al.
Published: (2023-09-01)

Neurobiology, Pathophysiology, and Treatment of Melatonin Deficiency and Dysfunction
by: Rüdiger Hardeland
Published: (2012-01-01)

Dynamics of Dynamin-Related Protein 1 in Alzheimer’s Disease and Other Neurodegenerative Diseases
by: Darryll Oliver, et al.
Published: (2019-08-01)

Sleep, Melatonin, and the Menopausal Transition: What Are the Links?
by: Shazia Jehan, et al.

Melatonin, Its Metabolites and Their Interference with Reactive Nitrogen Compounds
by: Rüdiger Hardeland
Published: (2021-07-01)

Cellular Mechanisms of Melatonin: Insight from Neurodegenerative Diseases
by: Dongmei Chen, et al.
Published: (2020-08-01)

Melatonin in plants – diversity of levels and multiplicity of functions
by: Ruediger eHardeland
Published: (2016-02-01)

Differentiation of Alzheimer's disease from other neurodegenerative disorders using chemiluminescence immunoassays measuring cerebrospinal fluid biomarkers
by: Philipp Arendt, et al.
Published: (2024-10-01)

Digital endpoints in clinical trials of Alzheimer’s disease and other neurodegenerative diseases: challenges and opportunities
by: Anna-Katharine Brem, et al.
Published: (2023-06-01)

Neuroprotective effects of carvacrol against Alzheimer’s disease and other neurodegenerative diseases: A review
by: Zahra Azizi, et al.
Published: (2022-07-01)

Use of C. elegans as a Model to Study Alzheimer’s Disease and Other Neurodegenerative Diseases
by: Adanna G Alexander, et al.
Published: (2014-09-01)

Ocular Manifestations of Alzheimer’s and Other Neurodegenerative Diseases: The Prospect of the Eye as a Tool for the Early Diagnosis of Alzheimer’s Disease
by: Pade Colligris, et al.
Published: (2018-01-01)

Divergent Importance of Chronobiological Considerations in High- and Low-dose Melatonin Therapies
by: Rüdiger Hardeland
Published: (2021-03-01)

The Reserve/Maximum Capacity of Melatonin’s Synthetic Function for the Potential Dimorphism of Melatonin Production and Its Biological Significance in Mammals
by: Dun-Xian Tan, et al.
Published: (2021-12-01)

Corrigendum: Differentiation of Alzheimer's disease from other neurodegenerative disorders using chemiluminescence immunoassays measuring cerebrospinal fluid biomarkers
by: Philipp Arendt, et al.
Published: (2025-02-01)

Chromatic pupillometry for evaluating melanopsin retinal ganglion cell function in Alzheimer’s disease and other neurodegenerative disorders: a review
by: Martina Romagnoli, et al.
Published: (2024-01-01)

Text mining and portal development for gene-specific publications on Alzheimer’s disease and other neurodegenerative diseases
by: Jiannan Liu, et al.
Published: (2024-04-01)

COMPARISON OF POTENTIAL PLASMA BIOMARKERS IN ALZHEIMER’S DISEASE AND OTHER NEURODEGENERATIVE DEMENTIAS IN PAKISTANI POPULATION
by: Tehniat Ahmed, et al.
Published: (2023-10-01)

Pharmacotherapy of Insomnia with Ramelteon: Safety, Efficacy and Clinical Applications
by: Seithikurippu R. Pandi-Perumal, et al.
Published: (2011-04-01)

Neuroprotective effects of melatonin in neurodegenerative and autoimmune central nervous system diseases
by: Jung-Won Shin
Published: (2023-04-01)

Melatonin as an Anti-Aging Therapy for Age-Related Cardiovascular and Neurodegenerative Diseases
by: Virna Margarita Martín Giménez, et al.
Published: (2022-06-01)

Glaucoma and Alzheimer: Neurodegenerative disorders show an adrenergic dysbalance
by: Bettina Hohberger, et al.
Published: (2022-01-01)

Glaucoma and Alzheimer: Neurodegenerative disorders show an adrenergic dysbalance.
by: Bettina Hohberger, et al.
Published: (2022-01-01)